Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Discovery Medicine|August 14, 2010
The promise of bispecific antibodiesPeter Kufer, Ralf Lutterbüse, Patrick A BaeuerleCurrent Opinion in Molecular Therapeutics|September 30, 2003
Bispecific antibodies for polyclonal T-cell engagementPatrick A Baeuerle, Peter Kufer, Ralf LutterbüseCurrent Opinion in Molecular Therapeutics|January 27, 2009
BiTE: Teaching antibodies to engage T-cells for cancer therapyPatrick A Baeuerle, Peter Kufer, Ralf BargouPharmacology & Therapeutics|September 4, 2012
Blinatumomab: a historical perspectiveDirk Nagorsen, Peter Kufer, Patrick A Baeuerle, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cellsJuergen M Schanzer, Iduna Fichtner, Patrick A Baeuerle, et al.Cancer Immunity|February 18, 2006
A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cellsJuergen M Schanzer, Patrick A Baeuerle, Torsten Dreier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2016
A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non-Small Cell Lung CancerIngo Mecklenburg, Wulf Sienel, Severin Schmid, et al.Drug Discovery Today|October 11, 2005
BiTEs: bispecific antibody constructs with unique anti-tumor activityEvelyn Wolf, Robert Hofmeister, Peter Kufer, et al.Molecular Immunology|December 20, 2005
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cellsSonja Offner, Robert Hofmeister, Andrea Romaniuk, et al.Plos One|October 29, 2015
Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110Wibke Deisting, Tobias Raum, Peter Kufer, et al.Pageof 6